Table 2 Treatment of patients with HR + , HER2-, pT1-3 invasive ductal or lobular cancer
IDC | ILC | p-value* | |
|---|---|---|---|
n (%) | n (%) | ||
Surgery | 0.52 | ||
No | 4 (0.3) | 1 (0.4) | |
Yes | 1581 (99.7) | 256 (99.6) | |
Missing | 1 | 0 | |
Adjuvant chemotherapy | 0.022 | ||
No | 1024 (64.8) | 147 (57.2) | |
Yes | 556 (35.2) | 110 (42.8) | |
Missing | 6 | 0 | |
Radiotherapy | 0.018 | ||
No | 321 (20.5) | 68 (27.1) | |
Yes | 1247 (79.5) | 183 (72.9) | |
Missing | 18 | 6 | |
Endocrine therapy | 0.1 | ||
No | 81 (5.1) | 7 (2.8) | |
Yes | 1497 (94.9) | 247 (97.2) | |
Missing | 8 | 3 | |